Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    November 2018
  1. LLORENTE BARRIO M, Garcia Lopez S, Gilaberte Calzada Y, Monzon Baez RM, et al
    Bilateral pyoderma gangrenosum associated with ulcerative colitis and restorative proctocolectomy.
    Gastroenterol Hepatol. 2018 Nov 20. pii: S0210-5705(18)30285.
    PubMed     Text format    


    October 2018
  2. RODRIGUEZ-LAGO I, Ferreiro-Iglesias R, Nos P, Gisbert JP, et al
    Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey.
    Gastroenterol Hepatol. 2018 Oct 4. pii: S0210-5705(18)30251.
    PubMed     Text format     Abstract available


  3. GUARDIOLA J, Lobaton T, Cerrillo E, Ferreiro-Iglesias R, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018;41:514-529.
    PubMed     Text format     Abstract available


    August 2018
  4. SANCHEZ RODRIGUEZ E, Rios Leon R, Mesonero Gismero F, Albillos A, et al
    Clinical experience of optimising thiopurine use through metabolite measurement in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Aug 11. pii: S0210-5705(18)30205.
    PubMed     Text format     Abstract available


    July 2018
  5. NUNEZ-GOMEZ L, Mesonero-Gismero F, Albillos-Martinez A, Lopez-Sanroman A, et al
    Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease.
    Gastroenterol Hepatol. 2018 Jul 24. pii: S0210-5705(18)30195.
    PubMed     Text format     Abstract available


  6. IBORRA M, Beltran B, Maroto N, Navarro-Cortes P, et al
    Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents.
    Gastroenterol Hepatol. 2018 Jul 18. pii: S0210-5705(18)30186.
    PubMed     Text format     Abstract available


    June 2018
  7. YAMAMOTO-FURUSHO JK, Sarmiento-Aguilar A, Garcia-Alanis M, Gomez-Garcia LE, et al
    Hospital Anxiety and Depression Scale (HADS): Validation in Mexican Patients with Inflammatory Bowel Disease.
    Gastroenterol Hepatol. 2018 Jun 21. pii: S0210-5705(18)30138.
    PubMed     Text format     Abstract available


    May 2018
  8. GISBERT JP, Chaparro M
    Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review.
    Gastroenterol Hepatol. 2018 May 9. pii: S0210-5705(18)30108.
    PubMed     Text format     Abstract available


  9. RODRIGUEZ-LAGO I, Benitez JM, Garcia-Sanchez V, Gutierrez A, et al
    Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view.
    Gastroenterol Hepatol. 2018 May 5. pii: S0210-5705(18)30110.
    PubMed     Text format     Abstract available


    April 2018
  10. SUAREZ FERRER C, Poza Cordon J, Cerpa Arencibia A, Sanchez Azofra M, et al
    Perspectiva actual hospitalization in inflammatory bowel disease: Current perspective.
    Gastroenterol Hepatol. 2018 Apr 7. pii: S0210-5705(18)30034.
    PubMed     Text format    


    March 2018
  11. FRAILE LOPEZ M, de Francisco R, Perez-Martinez I, Garcia Garcia B, et al
    Pyoderma gangrenosum and primary cutaneous cryptococcosis in an ulcerative colitis patient.
    Gastroenterol Hepatol. 2018 Mar 5. pii: S0210-5705(18)30050.
    PubMed     Text format    


    February 2018
  12. GOBBO M, Carmona L, Panadero A, Canas M, et al
    The psychosocial impact of inflammatory bowel disease and its management. From the patients' perspective.
    Gastroenterol Hepatol. 2018 Feb 5. pii: S0210-5705(18)30006.
    PubMed     Text format    


  13. MERINO RODRIGUEZ E, Carrera Alonso E, Torralba Gonzalez de Suso M, Sanchez da Silva M, et al
    Ionizing diagnostic radiation exposure in patients with Crohn's disease: A retrospective study in a medium hospital and its predictive factors.
    Gastroenterol Hepatol. 2018;41:97-102.
    PubMed     Text format     Abstract available


    January 2018
  14. BERMEJO F, Aguas M, Chaparro M, Domenech E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of tiopurines in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Jan 18. pii: S0210-5705(17)30248.
    PubMed     Text format     Abstract available


    December 2017
  15. BARREIRO-DE ACOSTA M, Marin-Jimenez I, Panadero A, Guardiola J, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease pa
    Gastroenterol Hepatol. 2017 Dec 20. pii: S0210-5705(17)30244.
    PubMed     Text format     Abstract available


  16. DE LA PISCINA PR, Delgado E, Duca I, Estrada S, et al
    Acute infection due to Mycobacterium marinum in a patient with ulcerative colitis and metabolic syndrome on infliximab therapy.
    Gastroenterol Hepatol. 2017 Dec 16. pii: S0210-5705(17)30241.
    PubMed     Text format    


    September 2017
  17. GONZALEZ ALAYON C, Pedrajas Crespo C, Marin Pedrosa S, Benitez JM, et al
    Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life.
    Gastroenterol Hepatol. 2017 Sep 9. pii: S0210-5705(17)30189.
    PubMed     Text format     Abstract available


  18. SANZ SANZ J, Juanola Roura X, Seoane-Mato D, Montoro M, et al
    Screening of Inflammatory Bowel Disease and Spondyloarthritis for Referring Patients Between Rheumatology and Gastroenterology.
    Gastroenterol Hepatol. 2017 Sep 4. pii: S0210-5705(17)30184.
    PubMed     Text format     Abstract available


    August 2017
  19. GUERRERO PUENTE L, Iglesias Flores E, Benitez JM, Medina Medina R, et al
    Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission.
    Gastroenterol Hepatol. 2017 Aug 30. pii: S0210-5705(17)30182.
    PubMed     Text format     Abstract available


  20. AGUAS M, Del Hoyo J, Faubel R, Valdivieso B, et al
    Telemedicine in the treatment of patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Aug 7. pii: S0210-5705(17)30166.
    PubMed     Text format     Abstract available


    July 2017
  21. TORRES P, Lobaton T, Canete F, Clos A, et al
    Cytomegalovirus primoinfection in inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Jul 19. pii: S0210-5705(17)30161.
    PubMed     Text format    


    June 2017
  22. AGUD FERNANDEZ M, Lopez Lopez F, Diaz Pedroche C, Gomez-Martin C, et al
    Concurrent inflammatory bowel disease and gastrointestinal stromal tumor.
    Gastroenterol Hepatol. 2017 Jun 24. pii: S0210-5705(17)30136.
    PubMed     Text format    


  23. DOMENECH E, Lopez-Sanroman A, Nos P, Vera M, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the monitoring, prevention and treatment of post-operative recurrence in Crohn's disease.
    Gastroenterol Hepatol. 2017 Jun 9. pii: S0210-5705(17)30126.
    PubMed     Text format     Abstract available


    February 2017
  24. SEBASTIAN DOMINGO JJ
    Review of the role of probiotics in gastrointestinal diseases in adults.
    Gastroenterol Hepatol. 2017 Feb 6. pii: S0210-5705(17)30003.
    PubMed     Text format     Abstract available


    December 2016
  25. MONTESERIN L, Jimenez M, Molina G, Reyes N, et al
    Colonic pseudopolyposis in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016 Dec 21. pii: S0210-5705(16)30161.
    PubMed     Text format    


    September 2016
  26. GARCIA-LOPEZ S
    Inflammatory bowel disease in Digestive Disease Week 2016: advances in epidemiology, follow-up, treatment monitoring, optimisation and individual tailoring, and colon cancer prevention.
    Gastroenterol Hepatol. 2016;39 Suppl 1:29-35.
    PubMed     Text format     Abstract available


  27. CHAPARRO M
    Treatment of inflammatory bowel disease: what's new in Digestive Disease Week 2016.
    Gastroenterol Hepatol. 2016;39 Suppl 1:20-28.
    PubMed     Text format     Abstract available


  28. GOMOLLON F
    Treatment adherence is always worse than we think: an unresolved problem in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016;39 Suppl 1:14-19.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: